49 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Duodenal Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Not yet recruiting The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Condition: Peptic Ulcer
Interventions: Drug: Ilaprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole
3 Recruiting Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy
Conditions: Gastritis;   Peptic Ulcer;   Dyspepsia
Interventions: Drug: Berberine;   Drug: clarithromycin;   Drug: Bismuth;   Drug: Lansoprazole;   Drug: amoxicillin
4 Not yet recruiting The Oral Microbiota as Reservoir for Systemic Opportunistic Pathogens
Conditions: Peptic Ulcer;   Pulmonary Disease, Chronic Obstructive;   Dental Plaque
Intervention: Procedure: Dental cleaning
5 Recruiting The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers
Condition: Peptic Ulcer
Interventions: Drug: Lafutidine;   Drug: Irsogladine maleate
6 Recruiting Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy
Conditions: Periampullary Tumor;   Common Bile Duct Neoplasms;   Duodenal Neoplasms
Intervention: Drug: Preoperative hyperbaric oxygen
7 Recruiting Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Condition: Peptic Ulcer
Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole;   Drug: histamine-2 receptor antagonist group famotidine
8 Recruiting Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: oral esomeprazole 20 mg twice daily;   Drug: oral esomeprazole 20 mg once daily
9 Not yet recruiting Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery
Conditions: Gastric Cancer;   Pancreatic Cancer;   Bile Duct Cancer;   Duodenal Cancer
Interventions: Drug: The marketed product 2-5 MBq/kg 18F-fluorodeoxyglucose;   Device: EnLightTM;   Device: LightPathTM Imaging System
10 Recruiting WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy
Conditions: Peptic Ulcer;   Gastric Cancer;   Esophagus Cancer;   Oesophagitis;   Hypoxia
Interventions: Device: WEI NASAL JET;   Device: Nasopharyngeal airway without jet ventilator
11 Recruiting Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
Condition: Peptic Ulcer Bleeding
Interventions: Device: Supplementary endoscopy with doppler-guided therapy;   Drug: IV. PPI;   Other: Endoscopic treatment at primary endoscopy
12 Recruiting Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
Conditions: Gastric Ulcer,;   Duodenal Ulcer
Intervention: Other: No Intervention
13 Recruiting Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Condition: Peptic Ulcer
Interventions: Drug: histamine-2 receptor antagonist (famotidine);   Drug: Placebo;   Drug: thienopyridine
14 Recruiting Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes
Condition: Ulcer Bleeding
Interventions: Procedure: epinephrine injection or heater probe or hemoclips;   Other: Observation only
15 Recruiting Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Condition: Peptic Ulcer
Interventions: Drug: Placebo;   Drug: PMK-S005 1;   Drug: PMK-S005 2;   Drug: PMK-S005 3
16 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
17 Recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
18 Recruiting The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: esomeprazole or pantoprazole;   Procedure: Endoscopic hemostasis
19 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
20 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years